273 related articles for article (PubMed ID: 16683273)
1. "Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study".
Cervinka P; Costa MA; Angiolillo DJ; Spacek R; Bystron M; Kvasnák M; Veselka J; Nanda H; Futamatsu H; Futamatsu K
Catheter Cardiovasc Interv; 2006 Jun; 67(6):846-51. PubMed ID: 16683273
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
[TBL] [Abstract][Full Text] [Related]
3. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
[TBL] [Abstract][Full Text] [Related]
4. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
[TBL] [Abstract][Full Text] [Related]
5. Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
Otake H; Honda Y; Courtney BK; Shimohama T; Ako J; Waseda K; Macours N; Rogers C; Popma JJ; Abizaid A; Ormiston JA; Spaulding C; Cohen SA; Fitzgerald PJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):146-54. PubMed ID: 21386089
[TBL] [Abstract][Full Text] [Related]
6. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Naka KK; Fotiadis DI; Michalis LK
JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755
[TBL] [Abstract][Full Text] [Related]
7. Comparison of sirolimus and paclitaxel-eluting stents for complex coronary lesions: an intravascular ultrasound study.
Cho YK; Hur SH; Kim HT; Kim IC; Park HS; Yoon HJ; Nam CW; Kim H; Han SW; Kim YN; Kim KB
Korean J Intern Med; 2009 Dec; 24(4):323-9. PubMed ID: 19949730
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease.
Kim YH; Park SW; Lee SW; Park DW; Yun SC; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ;
Circulation; 2006 Nov; 114(20):2148-53. PubMed ID: 17060388
[TBL] [Abstract][Full Text] [Related]
11. Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents.
Park KW; Kim CH; Lee HY; Kang HJ; Koo BK; Oh BH; Park YB; Kim HS
Am Heart J; 2010 Mar; 159(3):446-453.e3. PubMed ID: 20211308
[TBL] [Abstract][Full Text] [Related]
12. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
[TBL] [Abstract][Full Text] [Related]
13. Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
Jensen LO; Maeng M; Thayssen P; Villadsen A; Krusell L; Botker HE; Pedersen KE; Aaroe J; Christiansen EH; Vesterlund T; Hansen KN; Ravkilde J; Tilsted HH; Lassen JF; Thuesen L
EuroIntervention; 2011 Jul; 7(3):323-31. PubMed ID: 21729834
[TBL] [Abstract][Full Text] [Related]
14. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Chu WW; Kuchulakanti PK; Torguson R; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):62-6. PubMed ID: 16755592
[TBL] [Abstract][Full Text] [Related]
15. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
Futamatsu H; Sabaté M; Angiolillo DJ; Jimenez-Quevedo P; Corros C; Morikawa-Futamatsu K; Alfonso F; Jiang J; Cervinka P; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA
J Am Coll Cardiol; 2006 Sep; 48(6):1139-45. PubMed ID: 16978996
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: serial IVUS analysis of neointimal hyperplasia and luminal dimension.
Nakamura M; Abizaid A; Hirohata A; Honda Y; Sousa JE; Fitzgerald PJ
Catheter Cardiovasc Interv; 2007 Dec; 70(7):946-51. PubMed ID: 17621671
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus-versus paclitaxel-eluting stents: a comparison of two consecutive series in routine clinical practice.
Katritsis DG; Korovesis S; Karabinos I; Giazitzoglou E; Theodorou S; Karvouni E; Voridis E
J Interv Cardiol; 2006 Feb; 19(1):31-7. PubMed ID: 16483337
[TBL] [Abstract][Full Text] [Related]
18. Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus.
Kawaguchi R; Sabate M; Angiolillo DJ; Jimenez-Quevedo P; Suzuki N; Corros C; Futamatsu H; Alfonso F; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA
Int J Cardiovasc Imaging; 2008 Feb; 24(2):125-32. PubMed ID: 17541725
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
[TBL] [Abstract][Full Text] [Related]
20. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
